Kandalaft LE - Search Results

1

Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.

Fritah H, Graciotti M, Lai-Lai Chiang C, Huguenin-Bergenat AL, Petremand R, Ahmed R, Guillaume P, Schmidt J, Stevenson BJ, Gfeller D, Harari A, Kandalaft LE. Fritah H, et al. Among authors: kandalaft le. iScience. 2023 Feb 27;26(4):106288. doi: 10.1016/j.isci.2023.106288. eCollection 2023 Apr 21. iScience. 2023. PMID: 36950115 Free PMC article.

2

Conference scene: Immune signatures in the tumor and beyond.

Kandalaft LE, Kalos M, Melief CJ, Speiser DE, Coukos G. Kandalaft LE, et al. Immunotherapy. 2012 Aug;4(8):761-72. doi: 10.2217/imt.12.70. Immunotherapy. 2012. PMID: 22947003

3

Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin.

Kandalaft LE, Motz GT, Busch J, Coukos G. Kandalaft LE, et al. Curr Top Microbiol Immunol. 2011;344:129-48. doi: 10.1007/82_2010_95. Curr Top Microbiol Immunol. 2011. PMID: 20680802 Review.

4

Endothelin B receptor, a new target in cancer immune therapy.

Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Kandalaft LE, et al. Clin Cancer Res. 2009 Jul 15;15(14):4521-8. doi: 10.1158/1078-0432.CCR-08-0543. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567593 Free PMC article. Review.

5

Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.

Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L. Yan X, et al. Among authors: kandalaft le. Cancer Cell. 2015 Oct 12;28(4):529-540. doi: 10.1016/j.ccell.2015.09.006. Cancer Cell. 2015. PMID: 26461095 Free PMC article.

6

The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Kandalaft LE, Singh N, Liao JB, Facciabene A, Berek JS, Powell DJ Jr, Coukos G. Kandalaft LE, et al. Gynecol Oncol. 2010 Feb;116(2):222-33. doi: 10.1016/j.ygyno.2009.11.001. Epub 2009 Dec 2. Gynecol Oncol. 2010. PMID: 19959212 Free PMC article. Review.

7

Clinical translation section: accelerating the pace from bench to bedside.

Kandalaft LE, Coukos G. Kandalaft LE, et al. J Transl Med. 2011 Jul 21;9:116. doi: 10.1186/1479-5876-9-116. J Transl Med. 2011. PMID: 25928255 Free PMC article. No abstract available.

8

Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures.

Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A, Gumbleton M. Campbell L, et al. Among authors: kandalaft le. J Pharmacol Exp Ther. 2003 Jan;304(1):441-52. doi: 10.1124/jpet.102.042994. J Pharmacol Exp Ther. 2003. PMID: 12490621

9

Expression and transport functionality of FcRn within rat alveolar epithelium: a study in primary cell culture and in the isolated perfused lung.

Sakagami M, Omidi Y, Campbell L, Kandalaft LE, Morris CJ, Barar J, Gumbleton M. Sakagami M, et al. Among authors: kandalaft le. Pharm Res. 2006 Feb;23(2):270-9. doi: 10.1007/s11095-005-9226-0. Epub 2006 Jan 1. Pharm Res. 2006. PMID: 16382279

10

Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance.

Kandalaft LE, Motz GT, Duraiswamy J, Coukos G. Kandalaft LE, et al. Cancer Metastasis Rev. 2011 Mar;30(1):141-51. doi: 10.1007/s10555-011-9289-9. Cancer Metastasis Rev. 2011. PMID: 21298574 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters